SMITH HUNTER C (Chief Financial Officer) sold 5.6% of their position (7.07K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $708.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−1.91K
Price / share
$102.66
Trade value
$196.38K
% of position
Common Stock
Shares
−700.00
Price / share
$103.68
Trade value
$72.57K
% of position
Common Stock
Shares
−100.00
Price / share
$104.76
Trade value
$10.48K
% of position
Common Stock
Shares
−2.27K
Price / share
$98.37
Trade value
$222.91K
% of position
Common Stock
Shares
−400.00
Price / share
$99.44
Trade value
$39.77K
% of position
Common Stock
Shares
−100.00
Price / share
$100.85
Trade value
$10.09K
% of position
Common Stock
Shares
−292.00
Price / share
$96.26
Trade value
$28.11K
% of position
Common Stock
Shares
−400.00
Price / share
$97.67
Trade value
$39.07K
% of position
Common Stock
Shares
−800.00
Price / share
$98.99
Trade value
$79.19K
% of position
Common Stock
Shares
−100.00
Price / share
$100.10
Trade value
$10.01K
% of position
Net shares
−7.07K
Net value
-$708.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/10/2026 | S · Sale | −1.91K | $102.66 | $196.38K | 1.5% | 125.54K | 123.62K |
| Common Stock Direct | 2/10/2026 | S · Sale | −700.00 | $103.68 | $72.57K | 0.6% | 123.62K | 122.92K |
| Common Stock Direct | 2/10/2026 | S · Sale | −100.00 | $104.76 | $10.48K | 0.1% | 122.92K | 122.82K |
| Common Stock Direct | 2/11/2026 | S · Sale | −2.27K | $98.37 | $222.91K | 1.8% | 122.82K | 120.56K |
| Common Stock Direct | 2/11/2026 | S · Sale | −400.00 | $99.44 | $39.77K | 0.3% | 120.56K | 120.16K |
| Common Stock Direct | 2/11/2026 | S · Sale | −100.00 | $100.85 | $10.09K | 0.1% | 120.16K | 120.06K |
| Common Stock Direct | 2/12/2026 | S · Sale | −292.00 | $96.26 | $28.11K | 0.2% | 120.06K | 119.77K |
| Common Stock Direct | 2/12/2026 | S · Sale | −400.00 | $97.67 | $39.07K | 0.3% | 119.77K | 119.37K |
| Common Stock Direct | 2/12/2026 | S · Sale | −800.00 | $98.99 | $79.19K | 0.7% | 119.37K | 118.57K |
| Common Stock Direct | 2/12/2026 | S · Sale | −100.00 | $100.10 | $10.01K | 0.1% | 118.57K | 118.47K |
| Total | −7.07K | -$708.58K | ||||||
Restricted Stock Units
Common Stock
25K shares
Shares
+25K
Strike price
Held after
25K
Exercisable
—
Stock Options (Right to Buy)
Common Stock
37.50K shares
Shares
+37.50K
Strike price
98.47
Held after
37.50K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock25K shares | 2/11/2026 | A · Award | +25K | — | 25K | |
| Stock Options (Right to Buy) Direct | Common Stock37.50K shares | 2/11/2026 | A · Award | +37.50K | 98.47 | — | 37.50K |